Big pharma, Deals, Partnering, Pharma

Specialty Pharmaceuticals, Mylan, buys SEZ plant from Unichem for $26.27 million

Posted on 28 October 2013

Tags: , , ,

Unichem Laboratories is selling its Indore-based SEZ plant to generic and specialty pharmaceuticals maker Mylan Laboratories for Rs 161 crore ($26.27 million), as per a stock market disclosure.

Mumbai-headquartered Unichem makes pharmaceutical ingredients and pharmaceutical formulations for various therapeutic areas, including gastro-intestinal, cardiovascular, diabetes, psychiatry, neurology, anti-bacterial, anti-infectives and pain management

Hyderabad-based Mylan works as a subsidiary of US-based Mylan Inc. . The company manufactures and supplies active specialty pharmaceuticals ingredients.

For further deal information visit Current Agreements (subscription required)



Report: Partnering Deals and Alliances with Mylan

Read: more on Mylan company profile, recent partnering, M&A and financing news and articles

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply